Clinical Trial Update: PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prevention of atrial fibrillation in patients undergoing thoracic surgery for lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Lung Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Lung Cancer, Atrial Fibrillation | Phase 3 | Status: COMPLETED